MA32789B1 - Nouveau procede de preparation de granules de principes actifs et granules tels qu'ostenus - Google Patents

Nouveau procede de preparation de granules de principes actifs et granules tels qu'ostenus

Info

Publication number
MA32789B1
MA32789B1 MA33837A MA33837A MA32789B1 MA 32789 B1 MA32789 B1 MA 32789B1 MA 33837 A MA33837 A MA 33837A MA 33837 A MA33837 A MA 33837A MA 32789 B1 MA32789 B1 MA 32789B1
Authority
MA
Morocco
Prior art keywords
granules
active ingredients
preparation
new process
granules active
Prior art date
Application number
MA33837A
Other languages
Arabic (ar)
English (en)
Inventor
Christophe Lebon
Pascal Suplie
Original Assignee
Debregeas Et Associes Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40348849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA32789(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debregeas Et Associes Pharma filed Critical Debregeas Et Associes Pharma
Publication of MA32789B1 publication Critical patent/MA32789B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fertilizers (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
  • Seasonings (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne un procédé de préparation d'un granulé d'au moins deux principes actifs, comprenant une étape d'application par poudrage desdits principes actifs sur un support particulaire solide, lesdits principes actifs n'étant pas des extraits de plantes.
MA33837A 2008-11-14 2011-05-13 Nouveau procede de preparation de granules de principes actifs et granules tels qu'ostenus MA32789B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0857764A FR2938432B1 (fr) 2008-11-14 2008-11-14 Nouveau procede de preparation de granules de principes actifs, et granules tels qu'obtenus
PCT/FR2009/052180 WO2010055268A1 (fr) 2008-11-14 2009-11-13 Nouveau procédé de préparation de granulés de principes actifs, et granulés tels qu'obtenus

Publications (1)

Publication Number Publication Date
MA32789B1 true MA32789B1 (fr) 2011-11-01

Family

ID=40348849

Family Applications (1)

Application Number Title Priority Date Filing Date
MA33837A MA32789B1 (fr) 2008-11-14 2011-05-13 Nouveau procede de preparation de granules de principes actifs et granules tels qu'ostenus

Country Status (25)

Country Link
US (1) US20110280945A1 (fr)
EP (1) EP2349226A1 (fr)
JP (1) JP5608681B2 (fr)
KR (1) KR101585705B1 (fr)
CN (1) CN102223879A (fr)
AR (1) AR074330A1 (fr)
AU (1) AU2009315449B2 (fr)
BR (1) BRPI0916019A2 (fr)
CA (1) CA2743753A1 (fr)
CL (1) CL2011001115A1 (fr)
CO (1) CO6382108A2 (fr)
CU (1) CU20110107A7 (fr)
EA (1) EA201100757A1 (fr)
FR (1) FR2938432B1 (fr)
IL (1) IL212850A0 (fr)
MA (1) MA32789B1 (fr)
MX (1) MX2011005072A (fr)
NZ (1) NZ592857A (fr)
PE (1) PE20110945A1 (fr)
SG (1) SG195651A1 (fr)
TN (1) TN2011000235A1 (fr)
TW (1) TWI522113B (fr)
UA (1) UA103781C2 (fr)
WO (1) WO2010055268A1 (fr)
ZA (1) ZA201103543B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2971422B1 (fr) * 2011-02-11 2016-05-20 Debregeas Et Associes Pharma Granules d'acide gamma-hydroxybutyrique
US20140127296A1 (en) * 2012-11-05 2014-05-08 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US9241956B2 (en) * 2012-11-05 2016-01-26 Kenneth John Tibbs Pharmaceutical preparation and method for treatment of diabetes
US11058635B1 (en) * 2020-10-15 2021-07-13 King Abdulaziz University Oral administration of 5-FU in a gelling nanosuspension for targeted delivery to treat colorectal cancers

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6327424A (ja) * 1986-07-17 1988-02-05 Shionogi & Co Ltd 徐放性製剤およびその製造法
JP2820829B2 (ja) * 1991-03-07 1998-11-05 武田薬品工業株式会社 有核散剤およびその製造方法
JPH08310969A (ja) * 1995-05-22 1996-11-26 Lion Corp 固形薬品組成物及びその製造方法
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
WO2000069414A2 (fr) * 1999-05-17 2000-11-23 D.B.F. Granules contenant une substance vegetale et leur procede de preparation
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US9247765B2 (en) * 2004-01-14 2016-02-02 Omniactive Health Technologies Limited Stable beadlets of lipophilic nutrients
FR2880541B1 (fr) * 2005-01-10 2008-02-22 Amalric Veret Une nouvelle formule de plantes sous forme de micro-granules de xilitol pour renforcer les effets des plantes et leurs proprietes par une meilleure assimilation
US20060182796A1 (en) * 2005-02-03 2006-08-17 Abrika Pharmaceuticals, Inc. Taste masked pharmaceutical compositions
CA2661683C (fr) * 2006-08-31 2015-11-24 Eurand, Inc Systemes d'administration de medicament comprenant des solutions solides de medicaments faiblement basiques
CN101611099B (zh) * 2007-02-14 2013-01-02 大日精化工业株式会社 有机颜料的分散剂及其使用
US20090004281A1 (en) * 2007-06-26 2009-01-01 Biovail Laboratories International S.R.L. Multiparticulate osmotic delivery system

Also Published As

Publication number Publication date
WO2010055268A1 (fr) 2010-05-20
JP5608681B2 (ja) 2014-10-15
IL212850A0 (en) 2011-07-31
AU2009315449A1 (en) 2010-05-20
JP2012508786A (ja) 2012-04-12
US20110280945A1 (en) 2011-11-17
AR074330A1 (es) 2011-01-05
NZ592857A (en) 2013-07-26
TWI522113B (zh) 2016-02-21
BRPI0916019A2 (pt) 2015-11-10
MX2011005072A (es) 2011-10-03
TN2011000235A1 (fr) 2012-12-17
ZA201103543B (en) 2012-01-25
CA2743753A1 (fr) 2010-05-20
FR2938432B1 (fr) 2011-05-20
AU2009315449B2 (en) 2015-03-26
EP2349226A1 (fr) 2011-08-03
CO6382108A2 (es) 2012-02-15
CL2011001115A1 (es) 2011-11-11
TW201029667A (en) 2010-08-16
UA103781C2 (uk) 2013-11-25
KR101585705B1 (ko) 2016-01-15
SG195651A1 (en) 2013-12-30
KR20110095888A (ko) 2011-08-25
FR2938432A1 (fr) 2010-05-21
PE20110945A1 (es) 2012-02-01
EA201100757A1 (ru) 2011-12-30
CN102223879A (zh) 2011-10-19
CU20110107A7 (es) 2012-01-31

Similar Documents

Publication Publication Date Title
EA201170742A1 (ru) Производные n-{[(1r,4s,6r)-3-(2-пиридинилкарбонил)-3-азабицикло[4.1.0]гепт-4-ил]метил}-2-гетероариламинов и их применения
MX2008011107A (es) Catalizadores de metal de transicion fluorados y formacion de los mismos.
MA32789B1 (fr) Nouveau procede de preparation de granules de principes actifs et granules tels qu'ostenus
TW200700406A (en) Novel thiophene derivatives
TW200716591A (en) Novel thiophene derivatives
TW200716552A (en) Novel thiophene derivatives
TW200738670A (en) Novel thiophene derivatives
MX2009001188A (es) Compuestos quimicos.
UA96449C2 (en) Stable laquinimod preparations
TW200642750A (en) Fast-release microcapsule products
MX2010005889A (es) Derivados de tiofeno como agonistas de s1p1/edg1.
MY186831A (en) Mo containing catalyst, a preparation method and a method for preparing methyl mercaptan
MA33523B1 (fr) Microgranulés flottants
UA93424C2 (en) Preparation of azoxystrobin
WO2008113559A3 (fr) Indolizines et dérivés analogues aza de celles-ci en tant que composés actifs sur le système nerveux central
EA200970247A1 (ru) Способ получения оптического активного n-защищенного 3-аминопирролидина или оптически активного n-защищенного 3-аминопиперидина и соответствующих кетонов путем оптического разделения рацемических смесей аминов с использованием бактериальной омега-трансаминазы
WO2007021970A3 (fr) Formes pharmaceutiques stables et methodes d'utilisation de celles-ci
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
ATE551328T1 (de) Neuartige 5-substituierte hydantoine
GB0619984D0 (en) Chromatographic stationary phase
MA33679B1 (fr) Derives de 2-oxo-1-pyrrolidinyle imidazothiadiazole
WO2008097819A3 (fr) Composés chimiques
MA29770B1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation
ZA202207729B (en) Solid state form of pyroxasulfone
TW200508197A (en) Indolone-acetamide derivatives, processes for preparing them and their uses